Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Share News (CLL)

  • There is currently no data for CLL

Cello cuts costs to offset slowdown

Fri, 03rd Jul 2009 07:50
A slowdown at its qualitative research business has prompted Cello to caution like for like gross profits are down by around 10% year on year, with operating margins also squeezed.The market research group has cut costs to offset the downturn. Like for like professional costs have been reduced by around 7%. The cost reduction measures outlined above have resulted in an exceptional cost of around £0.4m in the first half. Overall, Cello says a full year headline operating profit in line with the current market consensus is achievable."Core revenue visibility remains solid as contract retention has proved to be good. The group has also continued to take prudent action to adjust the cost base and remains alert to taking further action where necessary," it adds.

Related News

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition
7 Aug 2020

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover
4 Aug 2020

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

Arsenal Capital makes £179m offer for Cello Health
1 Jul 2020

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the compa...

CLL.L News

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition
7 Aug 2020

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Court Order Sanctions Arsenal's Cello Acquisition

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover
4 Aug 2020

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

IN BRIEF: Cello Health Gets Shareholder Approval For Arsenal Takeover

Arsenal Capital makes £179m offer for Cello Health
1 Jul 2020

Arsenal Capital makes £179m offer for Cello Health

(Sharecast News) - Cello Health said on Wednesday it had agreed to a takeover from private venture company Arsenal Capital Partners, valuing the compa...

UK Shareholder Meetings Calendar - Next 7 Days
13 May 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday broker round-up
8 Apr 2020

Wednesday broker round-up

(Sharecast News) - Travis Perkins: JP Morgan downgrades to underweight with a target price of 920p.

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition
7 Apr 2020

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

UK TRADING UPDATE SUMMARY: GCP Student Living Terminates Acquisition

Access Intelligence Records Widened Annual Loss As Expenses Rise
6 Apr 2020

Access Intelligence Records Widened Annual Loss As Expenses Rise

Access Intelligence Records Widened Annual Loss As Expenses Rise

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment
18 Mar 2020

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment

Cello Health Profit Falls On GBP2.7 Million Signal Agency Impairment